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Concentrations (including isomer patterns) and temporal changes (1997e2012) of perﬂuoroalkyl acids
(PFAAs) and selected perﬂuorooctane sulfonate (PFOS) and perﬂuoroalkyl carboxylic acid (PFCA) pre-
cursors were determined in serum samples from Swedish women. Perﬂuorooctane sulfonamide (FOSA)
and perﬂuorooctane sulfonamidoacetic acid (FOSAA), as well as its N-methyl and N-ethyl derivatives
(MeFOSAA and EtFOSAA) were consistently detected. Highest PFOS precursor concentrations were found
for EtFOSAA (before year 2000) or MeFOSAA and FOSAA (after 2000). Disappearance half-lives for all
PFOS precursors were shorter compared to PFOS. 4:2/6:2 and 6:2/6:2 polyﬂuoroalkyl phosphate diesters
(diPAPs) were detected in <60% of the samples, whereas 6:2/8:2 and 8:2/8:2 diPAPs were detected in
>60% of the samples, but showed no signiﬁcant change in concentrations over time. Linear and sum-
branched isomers were quantiﬁed separately for three PFAAs and three precursors. Signiﬁcant
changes between 1997 and 2012 in the % linear isomer were observed for PFOA and FOSA (increase) and
PFOS (decrease).
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Per- and polyﬂuoroalkyl substances (PFASs) are chemicals that
have been used in industrial applications and in consumer products
since the 1950s, and have been identiﬁed as environmental pol-
lutants with perﬂuoroalkane sulfonic acids (PFSAs) and per-
ﬂuoroalkyl carboxylic acids (PFCAs) as major compound classes of
concern (Buck et al., 2011). PFSAs and PFCAs are persistent in the
environment and their long-chain homologues (C6 PFSAs andC8
PFCAs) have bioaccumulative properties. There are, however, also
PFASs that are less persistent and that can undergo transformation.
Methyl and ethyl perﬂuorooctane sulfonamidoethanols (Me- and
EtFOSE) and perﬂuorooctane sulfonamides (Me- and EtFOSA) are
PFASs that have been identiﬁed as precursors to perﬂuorooctane
sulfonic acid (PFOS) (Benskin et al., 2009; Peng et al., 2014; Xie
et al., 2009). The manufacturing of PFOS and its precursors resul-
ted in a mixture of linear and branched isomers (Martin et al.,
2010), and production was phased out by the main manufacturerGebbink).
istry, Helmholtz Centre for
rmany.
Ltd. This is an open access article ubetween 2000 and 2002 in North America and Europe.
Fluorotelomer-based chemicals such as polyﬂuoroalkyl phosphate
esters (PAPs) have been identiﬁed as precursors to PFCAs (D'Eon
and Mabury, 2011a). The production of ﬂuorotelomer-based
chemicals (producing only linear isomers) is still ongoing, howev-
er, industry has committed to reduce production of PFCAs with a
chain length C8 and other ﬂuorinated chemicals that can degrade
to these PFCAs, and to eliminate emissions of these chemicals by
2015 (US EPA, 2006).
External human exposure to PFOS isomers, PFCAs and pre-
cursors has recently been estimated by Gebbink et al. (2015a).
Exposure pathways such as ingestion of food, dust, and drinking
water and inhalation of air were all identiﬁed as sources of PFOS,
PFCAs and/or their precursors to humans. Cumulative exposure
intakes of PFOS precursors were estimated to be comparable to the
daily intakes of PFOS itself, while daily intakes of 6:2, 8:2, and 10:2
ﬂuorotelomer based chemicals were higher compared to per-
ﬂuorohexanoic acid (PFHxA), perﬂuorooctanoic acid (PFOA) and
perﬂuorododecanoic acid (PFDA). In Sweden, diet and drinking
water have been identiﬁed as exposure pathways for the general
population for PFOS and its precursors (FOSA, perﬂuorooctane
sulfonamidoacetic acid (FOSAA) and its methyl and ethyl de-
rivatives (MeFOSAA and EtFOSAA)), while the diet was a source ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2015b; Ullah et al., 2014). In food basket samples and herring, the
relative importance of precursors for PFAA exposure has recently
decreased over time (Gebbink et al., 2015b; Ullah et al., 2014),
however, such temporal trend studies for other exposure pathways
are lacking.
With respect to human biomonitoring, PFSAs and PFCAs have
been studied extensively in different populations (Glynn et al.,
2012; Haug et al., 2009; Kato et al., 2011; Yeung et al., 2013a,
2013b). For most of these populations, declining temporal trends
in serum were seen for PFSAs and in particular PFOS. This was
linked to the phase out of PFOS and related chemicals by industry in
2002. For longer chain length PFCAs (>C8), increasing trends were
often observed in the studied populations. Recently, human bio-
monitoring studies have reported a variety of precursor com-
pounds. FOSAA, MeFOSAA, and EtFOSAA, as well as diPAPs were
detected in human serum from the US, Germany, and Hong Kong
(D'Eon et al., 2009; Lee and Mabury, 2011; Loi et al., 2013; Olsen
et al., 2004; Yeung et al., 2013a, 2013b). Declining temporal
trends were seen in whole blood or serum for PFOS precursors,
while diPAP concentrations and detection frequency were gener-
ally low. In Swedish serum samples only the PFOS precursor FOSA
was analyzed so far with rapidly declining concentrations between
1996 and 2010 (Glynn et al., 2012). On the other hand, Liu et al.
(2015) recently suggested that the relative importance of PFOS
precursors for total internal exposure to PFOS has increased in the
Swedish population (based on isomer and enantiomer pattern
biomarkers). However, it is unclear which PFOS precursors (other
than FOSA) and PFCA precursors the Swedish population has been
and still is exposed to.
The ﬁrst aim of this study was to investigate the presence,
concentrations, and temporal changes of PFAAs and selected pre-
cursors in serum samples donated by nursing primiparous women
from Uppsala, Sweden, between 1997 and 2012. Using a more
sensitive analytical method compared to Glynn et al. (2012),
quantitative data for a larger range of PFAA homologues were ob-
tained. The second aim was to investigate whether temporal
changes in the relative contribution of branched and linear PFAA
and precursor isomers in serum could shed light on the importance
of precursors for total human exposure to PFAAs and therewith
conﬁrm the ﬁndings for PFOS by Liu et al. (2015). The serum sam-
ples were analyzed for the following PFASs: C4,6,8,10 PFSAs, C4-14
PFCAs, FOSA and FOSAA and their N-methyl and N-ethyl de-
rivatives, as well as 4 monoPAPs and 11 diPAPs.
2. Material and methods
2.1. Chemicals and reagents
Native and labeled standards of PFSAs, PFCAs, FOSAs, FOSAAs,
andmono- and diPAPs used in this study are listed in Table S1 in the
Supporting Information. All solvents and reagents were of the
highest commercial purity and employed as received.
2.2. Serum samples
Between 1996 and 2012 primiparous women living in Uppsala
County, Sweden, donated blood samples within the fourth week
after delivery for a study on temporal trends of persistent haloge-
nated organic compounds in pregnant and nursing women, the
POPUP study (Persistent Organic Pollutants in Uppsala Primiparas)
(Glynn et al., 2012; Lignell et al., 2009). In the present study, per
year, 30 individual serum samples were pooled into 3 pools (9 or 10
individual samples per pool). Serum pools from the following years
were included in this study: 1997 (each of the three poolscontained two individual serum samples collected in 1996), 1998,
2000, 2002, 2004, 2006, 2008, 2010, and 2012 (Table S2). For each
year, two aliquots of all three serum pools were analyzed. The study
was approved by the regional ethical vetting board in Uppsala,
Sweden, and the participating women gave informed consent
before donating the blood samples.
2.3. Sample preparation
The extraction and clean-up of the samples is based on pub-
lished methods (Gebbink et al., 2013, 2015b). Brieﬂy, serum sam-
ples (1 g) were spiked with labeled internal standards (500 pg each,
see Table S1 for all internal standards used) and 3 mL acetonitrile
were added. The samples were mixed by vortex and placed in a
sonication bath for 15 min, after which the samples were centri-
fuged for 5 min at 3000 rpm. The organic phasewas transferred to a
separate tube and the extraction procedure was repeated. The
combined extracts were concentrated to ~1 mL under a stream of
nitrogen. SPE WAX cartridges (150 mg, 6 mL, Waters) were condi-
tioned with 6 mL methanol and 6 mL water. The sample extracts
were loaded onto the WAX columns and the columns were washed
with 1 mL 2% aqueous formic acid and then with 2 mL water. The
columns were dried by applying a vacuum and by centrifugation
before neutral compounds were eluted with 3 mL methanol (frac-
tion 1). The ionic compounds were subsequently eluted with 4 mL
of a solution of 1% ammonium hydroxide in methanol (fraction 2).
Both fractions were dried under a stream of nitrogen and the re-
siduals were redissolved in 150 mL of methanol. The extracts were
ﬁltered using centrifugal ﬁlters (modiﬁed nylon 0.2 mm, 500 mL,
VWR International) and 13C8-PFOA and 13C8-PFOS (500 pg each)
were added as recovery internal standards prior to ultra-
performance liquid chromatography-tandem mass spectrometry
(UPLC/MS/MS) analysis.
2.4. Instrumental analysis and quantiﬁcation
Fraction 1 was analyzed for FOSAs, while fraction 2 was
analyzed twice, ﬁrst for PFSAs, PFCAs, and FASAAs and then for
mono- and diPAPs. For all instrumental analyses, separation was
carried out on an Acquity UPLC system (Waters) equipped with a
BEH C18 (50  2.1 mm, 1.7 mm particle size, Waters) analytical
column. Mobile phases were (A) 95% water and 5% methanol and
(B) 75% methanol, 20% acetonitrile, and 5% water. Both mobile
phases contained 2 mM ammonium acetate and 5 mM 1-methyl
piperidine. The column temperature was set at 40 C, and the in-
jection volume was 5 mL. Mobile phases, the gradient programs and
ﬂow rates for the different UPLC methods can be found in Tables S3
and S4. Connected to the UPLC system was a Xevo TQ-S triple
quadrupole mass spectrometer (Waters) operated in negative ion
electrospray ionization (ESI) mode. The capillary voltage was set
at 3.0 kV, and the source and desolvation temperatures were 150 C
and 350 C, respectively. The desolvation and cone gas ﬂows (ni-
trogen) were set at 650 L/h and 150 L/h, respectively. Compound-
speciﬁcally optimized cone voltages and collision energies are lis-
ted in Table S1.
Quantiﬁcation was performed using an internal standard
approach. Analytes lacking an analogous labeled standard were
quantiﬁed using the internal standard with the closest retention
time (Table S1). Quantiﬁcation was performed using the precursor
e product ion multiple reaction monitoring (MRM) transitions re-
ported in Table S1. For all precursor compounds an additional
product ion was monitored for conﬁrmation. For diPAPs for which
no authentic standards were available, a technical mixture was
used to optimize MRM channels and for conﬁrmation of retention
times (Gebbink et al., 2013). Quantiﬁcation of these diPAPs was
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similar chain length (Table S1). Results for these compounds should
be considered semi-quantitative. For each compound a nine point
calibration curve was made ranging from 0.03 to 300 pg/mL for
PFAAs and 0.003e30 pg/mL for precursors. Calibration curves were
linear over the whole concentration ranges with r values greater
than 0.99 for all compounds.
The linear isomer and the sum of branched isomers of PFHxS,
PFOS, FOSA, MeFOSAA, EtFOSAA, and PFOA were chromatographi-
cally separated and quantiﬁed individually. Branched isomers were
quantiﬁed using the linear isomer calibration curve. For quantiﬁ-
cation of the sum of branched PFOS isomers an average of the
response obtained with the product ions m/z 80 and 99 was used
(Berger et al., 2011).2.5. Analytical quality control
In each batch of samples (n ¼ 10) three method blanks were
included tomonitor for background contamination. For compounds
where blank contamination was observed the method quantiﬁca-
tion limits (MQLs) were determined as the mean plus three times
the standard deviation of the quantiﬁed procedural blank signals. A
blank correction was performed by subtracting the average quan-
tiﬁed concentration in the blanks from PFAS concentrations in the
samples. For other compounds the MQL was determined as the
concentration in a serum sample giving a peak with a signal-to-
noise ratio of 10. Table S5 lists all compound-speciﬁc MQLs. Re-
coveries of the labeled internal standards in the serum samples are
listed in Table S6, and ranged between 40% and 92% with the
exception of 25% for d3-MeFOSA and 35% for 13C4-8:2/8:2 diPAP.Table 1
Temporal trends of PFAAs and precursors in Swedish serum samples collected be-
tween 1997 and 2012.
Compound Disappearance
half-life (yr)
Doubling time (yr) P
PFBS 0.61
br-PFHxS 10.2 0.0004
lin-PFHxS 11.8 0.0001
tot-PFHxS 11.7 0.0001
br-PFOS 9.2 <0.0001
lin-PFOS 8.5 <0.0001
tot-PFOS 8.7 <0.0001
PFDS 4.2 0.0007
br-FOSA 2.6 <0.0001
lin-FOSA 3.5 <0.0001
tot-FOSA 3.3 <0.0001
EtFOSAa
FOSAA 3.5 <0.0001
br-MeFOSAA 3.4 <0.0001
lin-MeFOSAA 3.5 <0.0001
tot-MeFOSAA 3.5 <0.0001
br-EtFOSAAa
lin-EtFOSAA 1.7 <0.0001
tot-EtFOSAA 1.8 <0.0001
PFHpA 0.26
br-PFOA 7.0 <0.0001
lin-PFOA 20.8 <0.0001
tot-PFOA 20.2 <0.0001
PFNA 15.9 <0.0001
PFDA 15.7 <0.0001
PFUnDA 16.3 <0.0001
PFDoDA 21.1 0.0003
PFTrDA 20.2 0.004
4:2/6:2 diPAPa
6:2/6:2 diPAPa
6:2/8:2 diPAP 0.13
8:2/8:2 diPAP 0.21
a Detection frequency <60%, therefore no trends were estimated.Together with the serum samples a NIST standard reference
material (SRM 1957) was analyzed in each batch. Concentrations
obtained for several PFAAs in SRM 1957 were lower compared to
the certiﬁed values, however, they were in agreement with re-
ported concentrations in other studies (Table S7). Relative standard
deviations (RSDs) for quantiﬁed concentrations in SRM 1957 (n¼ 9)
were<20% for PFAAs (with the exception of PFTrDA), <25% for PFOS
precursors, and between 15 and 57% for diPAPs. Duplicate analyses
of the pooled serum samples showed <10% deviation for PFHxS,
PFOS, and C8eC12 PFCAs, <25% deviation for PFBS, PFDS, PFHpA,
PFTrDA, FOSA and FOSAAs, and <35% deviation for diPAPs. Larger
variations were occasionally seen for compounds detected close to
their respective MQLs.
2.6. Data treatment and statistical analysis
Doubling times (DT) or disappearance half-lives (T½) of indi-
vidual compounds over the study period were only calculated
when the detection frequency was >60% in the serum pools and
when a signiﬁcant trend was observed (p < 0.05). Concentrations
below the MQLs were replaced with MQL/√2 for statistical data
treatment. Doubling times or disappearance half-lives were esti-
mated with T1/2 ¼ ln(2)/m, where m represents the slope of ln
transformed concentration versus time. Correlations between
concentrations of individual PFAAs and precursors in the serum
samples were analyzed by Pearson's correlation test. Temporal
changes in PFAA isomer patterns were only investigated when the
detection frequency of both linear and branched isomers was >60%
in the serum pools. Concentrations below the MQL were replaced
with MQL/√2.
3. Results and discussion
3.1. Temporal trends of PFAAs in serum samples
PFAAs have previously been analyzed in pooled serum samples
from the young mothers in the POPUP-cohort (Glynn et al., 2012;
Liu et al., 2015). Overall the present PFAA concentrations
(Tables S8 and S9) and temporal trends were in agreement with the
results reported in the earlier study (Table S10). However, some
differences were observed. For example, no signiﬁcant concentra-
tion change was seen in the serum samples for PFBS over the
presently studied time period (1997e2012). Glynn et al. (2012)
reported signiﬁcantly increasing concentrations between 1996
and 2010, which later was shown to be the result of a drinking
water contamination situation in the city of Uppsala
(Gyllenhammar et al., 2013). This contamination was also driving
the observed increase of the PFHxS concentration over the inves-
tigated time period (Gyllenhammar et al., 2013). PFUnDA, PFDoDA,
and PFTrDA were presently quantiﬁed in the serum samples with
signiﬁcantly increasing concentrations between 1997 and 2012
(Table 1), while these compounds were close to or below detection
limit in all samples in the earlier study (MDLs reported by Glynn
et al. (2012) were at least one order of magnitude higher
compared to the MQLs in the present study). FOSA concentrations
reported by Glynn and coworkers were systematically higher
compared to the present data; however, the calculated half-life of
FOSA was comparable. These differences could be attributed to one
or several of the following factors: (i) for the present study, serum
pools were freshly made and contained fewer individual serum
samples in pools from the early part of the study period, (ii)
different sample preparation and analytical techniques (including
different types of MS detectors) were used, (iii) there were differ-
ences in the quantiﬁcation procedure for, e.g., FOSA, and (iv) the
study design was different; Glynn et al. (2012) investigated a
Fig. 1. Temporal trends of PFOS and its precursors (ng/g ww, sum linear þ branched isomers) in pooled serum samples between 1997 and 2012. Disappearance half-lives (T½) are
provided for each compound.
Fig. 2. Relative abundance (%) of PFOS and its precursors (on a molar basis) in serum
samples from primiparous women collected between 1997 and 2012. Note that only
the range 80%e100% of the relative abundances is shown.
W.A. Gebbink et al. / Environmental Pollution 199 (2015) 166e173 169slightly different time period (1996e2010) and included samples
collected in all years (except 2003 and 2005) resulting in higher
statistical power compared to the present study with samples from
alternating years collected between 1997 and 2012.3.2. PFOS and its precursors in Swedish serum samples
Of the monitored PFOS precursors, FOSAA, MeFOSAA, EtFOSAA,
and FOSA were quantiﬁed in the serum samples from all years
included in this study (1997e2012) with declining concentrations
over time (p < 0.0001) (Tables 1, S11, and S12, and Fig. 1). The
concentrations in the individual samples ranged from 0.031 to
0.50 ng/g for FOSAA, 0.015e0.48 ng/g for MeFOSAA,
<0.002e1.54 ng/g for EtFOSAA, and 0.002e0.75 ng/g for FOSA
(Tables S11 and S12). EtFOSA was only detected in serum samples
collected in 2000, 2002, and 2004 with concentrations ranging
from 0.005 to 0.034 ng/g. PFOS concentrations in the serum sam-
ples were generally 1e2 orders of magnitude higher compared to
its precursors, and ranged between 5.6 and 20 ng/g. Signiﬁcant
positive correlations (p < 0.01) were observed betweenconcentrations of PFOS and its precursors, as well as among all
precursors (Table S13). The concentrations of FOSAAs in the present
Swedish serum samples were comparable to other European pop-
ulations, however, lower compared to US serum samples (Lee and
Mabury, 2011; Yeung et al., 2013b).
Exposure to the PFOS precursors detected in the present serum
samples (FOSA, FOSAA, MeFOSAA, and EtFOSAA) could have
occurred through different exposure pathways. Dust and food
ingestion have been identiﬁed as direct exposure pathways for Me-
and EtFOSAA (Beesoon et al., 2011; Gebbink et al., 2015b; Ullah
et al., 2014), but also intake of Me- and EtFOSE (e.g., through
inhalation of air and ingestion of dust (Shoeib et al., 2011)) and
subsequent transformation is a potential exposure source to Me-
and EtFOSAA (Peng et al., 2014). FOSAA has been reported in
chicken eggs obtained in Sweden (Gebbink et al., 2015b), however,
degradation of FOSEs could also be an indirect exposure pathway
for this ﬂuorinated chemical (Xu et al., 2004). FOSA detected in
human serum could originate from direct exposure through one or
more exposure pathways (diet, dust, drinking water, and air)
(Gebbink et al., 2015a) or from intakes of ﬂuorinated chemicals
such as Me- and EtFOSE, Me- and EtFOSAA, and/or Me- and EtFOSA
followed by biotransformation to FOSA (Peng et al., 2014).
Of the detected FOSAAs and FOSA in the serum samples, EtFO-
SAAwas the dominant precursor in 1997, 1998, and 2000, after this
year MeFOSAA and FOSAA were the dominant precursors, with
comparable concentrations to each other (Fig. 2). At all years FOSA
had the smallest relative abundance of all PFOS precursors. The
PFOS þ precursors pattern in serum pools was dominated by PFOS,
ranging from 91% (1997) to >99% (2010) (Fig. 2). Similar PFOS and
precursor patterns were also seen in a German population (Yeung
et al., 2013b). It should be stressed, though, that the relative
abundances shown in Fig. 2 refer to concentrations in serum only
and do thus not reﬂect total internal exposure, as the different
PFASs distribute differently in the human body. For example, unlike
ionic PFASs, FOSA has been reported to be more associated with the
blood cell fraction than with the serum (Hanssen et al., 2013); this
could possibly explain the low relative abundance of FOSA
compared to the other precursors in the serum samples.
Fig. 3. Concentrations of 4:2/6:2, 6:2/6:2, 6:2/8:2, and 8:2/8:2 diPAPs (pg/g ww) in pooled serum samples between 1997 and 2012. The detection frequency of each diPAP in the
serum pools and the signiﬁcance of the temporal trend (if detection frequency was >60%) are provided. The dashed line indicates a non-signiﬁcant temporal change in
concentration.
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serum samples ranged between 1.8 and 3.5 years, while for PFOS
the disappearance half-life was 8.7 years (Table 1 and Fig. 1). These
half-lives were also in accordance with PFOS half-lives reported for
two German populations (Yeung et al., 2013b). The observed
decreasing trends are likely the result of the production phase out
of PFOS and its precursors in 2002.
When comparing disappearance half-lives (Fig. 1) and inspect-
ing the PFOS þ precursor pattern in serum (Fig. 2), an apparent
decreasing trend in the relative importance of precursors for total
PFOS exposure is seen. Although this trend would be consistent
with the change in relative importance of (known) precursors in
Swedish food (Gebbink et al., 2015b; Ullah et al., 2014), Liu et al.
(2015) recently suggested that the relative importance of precur-
sor exposure in relation to PFOS exposure for the Swedish popu-
lation has actually increased since the late 1990s, based on isomer
and enantiomer pattern biomarker analyses in serum. These ob-
servations do not necessarily conﬂict with each other, since the
observed disappearance half-lives in serum are not only a function
of temporal changes of external exposure, but also of individual
PFAS pharmacokinetics (elimination half-lives including meta-
bolism for precursors). Furthermore, Gebbink et al. (2015a) esti-
mated that dust and air are dominant exposure media for
precursors over diet and the Swedish women may have been
exposed to PFOS precursors that were not analyzed in the present
or previous studies (through any of the mentioned exposure
pathways). In order to be able to unravel the role of PFOS precursors
for total human exposure to PFOS over time, knowledge of phar-
macokinetic parameters of all relevant PFOS precursors is essential,
but currently not available.
3.3. DiPAPs in Swedish serum samples
In the serum pools, 4:2/6:2, 6:2/6:2, 6:2/8:2, and 8:2/8:2 diPAPs
were detected, although detection of 4:2/6:2 and 6:2/6:2 diPAPs
was infrequent (<60%) (Fig. 3 and S1, Table S14). Four monoPAPs
(4:2, 6:2, 8:2, and 10:2) and seven other diPAP (4:2/4:2, 6:2/10:2,
8:2/10:2, 6:2/12:2, 10:2/10:2, 8:2/12:2, and 6:2/14:2) were below
their respective MQLs in the present samples. 6:2/6:2 and 8:2/8:2
diPAPs were generally quantiﬁed with higher concentrations in the
serum pools compared to 4:2/6:2 and 6:2/8:2 diPAPs. For 6:2/6:2
diPAP the concentrations above MQL ranged between 6.6 and
55 pg/g, and for 8:2/8:2 diPAP between 2.1 and 18 pg/g. Quantiﬁedconcentrations for 4:2/6:2 diPAP and 6:2/8:2 diPAP were below 1.3
and 2.7 pg/g, respectively. No signiﬁcant relationships were
observed between concentrations among the four detected diPAPs
(p > 0.05, Table S15). DiPAPs detected in the Swedish serum sam-
ples have also been found in German, Hong Kong, and US serum
samples (Lee andMabury, 2011; Loi et al., 2013; Yeung et al., 2013a).
Over the studied time period, temporal changes were only inves-
tigated for 6:2/8:2 and 8:2/8:2 diPAPs (detection frequency >60%),
however, no signiﬁcant temporal changes were observed (Table 1,
Fig. 3). The lack of temporal trends of diPAPs in the Swedish serum
pools is consistent with the absence of trends in Germans between
1982 and 2009 (Yeung et al., 2013a).
The Swedish population was recently exposed to six diPAPs
(4:2/6:2, 6:2/6:2, 6:2/8:2, 8:2/8:2, 6:2/10:2, and 10:2/10:2 diPAPs)
through their general diet, however, other diPAPs have also been
reported to occur in speciﬁc food samples (ﬁsh, popcorn, and potato
chips) (Gebbink et al., 2013, 2015b). Furthermore, dust and drinking
water have been identiﬁed as human exposure media containing
diPAPs (De Silva et al., 2012; Ding et al., 2012), however, not spe-
ciﬁcally in Sweden. From Swedish food basket samples (collected in
1999, 2005, and 2010) the 6:2/6:2 diPAP dietary intake was highest
in 1999 and decreased at each following time point, whereas the
dietary intakes for 4:2/6:2, 6:2/8:2, 8:2/8:2, 6:2/10:2, and 10:2/10:2
diPAPs peaked in 2005 (Gebbink et al., 2015b). Despite these in-
dications of changes over time in dietary exposure to diPAPs, no
temporal trends were observed in the serum samples. The detec-
tion frequencies of 4:2/6:2 and 6:2/6:2 diPAPs were too low in
order to determine any temporal change in concentrations,
whereas for 6:2/8:2 and 8:2/8:2 diPAPs indications of increasing
concentrations were seen over time, although this increase was not
signiﬁcant (Fig. 3). Although food contributes to human exposure to
diPAPs, dust was recently suggested to be the major exposure
medium for diPAPs (Gebbink et al., 2015a). This could explain why
the temporal variations in dietary intakes were not directly re-
ﬂected in the serum samples.
DiPAPs have been identiﬁed as PFCA precursors (D'Eon and
Mabury, 2011b). Therefore, relationships between diPAP and PFCA
concentrations were investigated. Potential degradation products
of the diPAPs detected in the present serum samples include C4eC9
PFCAs; however, of these PFCAs only PFHpA, PFOA, and PFNA were
detected whereas PFBA, PFPeA, and PFHxA were below their
respective MQLs. No signiﬁcant correlation was found between any
diPAP and their potential degradation products (Table S15).
Fig. 4. Temporal changes in the relative contribution of the linear isomer to sum linear þ branched isomers for PFHxS, PFOS, FOSA, MeFOSAA, and PFOA in human serum samples
between 1997 and 2012. A solid line indicates a signiﬁcant temporal change in the isomer pattern, whereas a dashed line indicates a non-signiﬁcant temporal change.
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to be higher compared to the corresponding PFCAs as degradation
products (Gebbink et al., 2015a); however, diPAP concentrations in
the present serum samples were lower compared to PFCA con-
centrations. Information regarding pharmacokinetic parameters
such as metabolism of diPAPs, elimination half-lives and/or volume
of distribution for individual PFCAs and diPAPs is either extremely
limited or non-existing. These knowledge gaps hinder the assess-
ment whether there were temporal changes in the relative
importance of diPAPs for total human exposure to PFCAs based on
the present dataset.
3.4. PFAA and precursor isomers in Swedish serum samples
In the present study the linear and the sum of all branched
isomers of several PFAAs and precursors were chromatographically
separated and quantiﬁed. Linear and branched isomers of PFHxS,
PFOS, and PFOAwere detected in all serum samples. For PFHxS, the
isomer pattern contained between 91.4% and 93.7% linear PFHxS,
linear PFOS contributed between 61.9% and 65.8% to total PFOS,
while the isomer pattern of PFOA contained between 97.8% and
99.2% linear PFOA (Fig. 4, Tables S8 and S9). Linear and branched
FOSA isomers were detected in all serum samples, while for
MeFOSAA and EtFOSAA the branched isomers were detected in 89%
and 33% of the serum pools, respectively (linear isomers were
detected in all samples) (Fig. 4, Tables S11 and S12). For FOSA the
linear isomer contributed between 70.3% and 94.9% to total FOSA,
while the percentage of the linear MeFOSAA and EtFOSAA isomer
ranged between 90.5%-97.9% and 97.8%e99.6%, respectively.
Over the studied time period, decreases were seen in the rela-
tive abundance of the linear PFHxS and PFOS isomer (although only
signiﬁcant for PFOS), while the PFOA isomer pattern was signiﬁ-
cantly enriched with the linear isomer between 1997 and 2012
(Fig. 4).
The relative abundance of linear FOSA and MeFOSAA increased
between 1997 and 2012; however, the increase was not signiﬁcant
for MeFOSAA (Fig. 4). Branched EtFOSAA isomers were only
detected in serum pools from 1997 to 2002; therefore, no temporal
changes were determined.
Reports on PFAA and/or precursor isomer patterns in humanserum are limited. PFOS and/or PFOA isomer patterns have been
reported in human serum from Sweden, Norway, China, and the US
(Berger et al., 2011; Glynn et al., 2012; Gützkow et al., 2012; Haug
et al., 2009; Liu et al., 2015; Zhang et al., 2013b). The PFOS and
PFOA isomer patterns reported in these studies, as well as temporal
changes in the PFOS isomer pattern are comparable to the present
study. To our knowledge, there are presently no literature data
available on temporal changes in PFHxS, FOSA, MeFOSAA, and
EtFOSAA isomer patterns in human serum samples.
Although PFOA isomer proﬁles have been reported in human
serum samples, no temporal changes in PFOA isomer pattern have
been investigated so far. PFOA has historically been produced by
both electrochemical ﬂuorination (ECF), resulting in ~78% linear
and ~22% sum branched PFOA (Zhang et al., 2013b), and by telo-
merization, exclusively producing the linear isomer. Information on
PFOA isomer patterns in human exposure media is extremely
limited. In Swedish drinking water the isomer pattern contained
>90% linear PFOA (Filipovic and Berger, 2015), however, drinking
water was estimated to only contribute 15% to the total PFOA in-
takes (Gebbink et al., 2015a). The observed PFOA isomer pattern
and its temporal trend in the serum samples (Fig. 4) could be
explained by several factors. (i) The production of ECF PFOA was
largely phased-out by 2002, whereas the production of telomer-
based PFOA and precursor chemicals is still ongoing; and (ii)
branched PFOA isomers are excreted faster than linear isomers
(Zhang et al., 2013a).
The major part of the cumulative historic production of PFOS
and its precursors occurred by ECF, producing a mixture of ~70%
linear and ~30% sum branched isomers (Martin et al., 2010). In-
formation on the isomer pattern of precursors in human exposure
media is extremely limited. FOSA isomer patterns have been re-
ported in Swedish food (with increasing importance of linear FOSA
in the isomer pattern between 1991 and 2011; Gebbink et al.,
2015b; Ullah et al., 2014), and in drinking water (Filipovic and
Berger, 2015), while for FOSAAs no information on isomer pat-
terns in exposure media is available. The enrichment of linear FOSA
in the isomer pattern over time seen in human serum (Fig. 4), in the
situation of generally decreasing levels (Fig. 1), is in line with the
trends observed in food. This trend could also (partly) be explained
by shorter disappearance half-lives of branched isomers compared
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biotransformation of branched isomers to branched PFOS relative
to the linear isomer (Benskin et al., 2009; Ross et al., 2012). Faster
urinary elimination of linear precursors relative to branched pre-
cursors, as was observed in humans (Zhang et al., 2013a), would, on
the other hand, result in increasing relative importance of branched
precursor isomers over time. Urinary elimination appears thus to
be a minor mechanism inﬂuencing the FOSA isomer patterns in the
present samples. Isomer-speciﬁc transformation of other ﬂuori-
nated chemicals present in the serum samples (MeFOSAA and
EtFOSAA) could also have inﬂuenced the FOSA isomer pattern.
Isomer patterns of PFOS have been reported in human exposure
media (dust, diet, drinking water, and/or air), as summarized by
Gebbink et al. (2015a). This study showed that the PFOS isomer
pattern of total PFOS intake largely reﬂects the isomer pattern in
food, since dietary intake is the dominant exposure pathway. In
Swedish food an increase in the relative abundance of the linear
isomer in the PFOS isomer pattern has been reported, from 81%
linear PFOS in 1999 to 91% in 2005 and 2010 (Gebbink et al., 2015b).
In all serum samples of the present study the PFOS isomer pattern
was enriched with branched isomers (33e40%) relative to the
isomer pattern reported in Swedish food. Furthermore, the serum
samples showed a decreasing abundance of linear PFOS in the
isomer pattern, which was opposite to the change in isomer pattern
in food. Faster biotransformation of branched precursors to
branched PFOS relative to linear precursors could have contributed
to increasing abundance of branched PFOS over time; however,
Gebbink et al. (2015a) recently estimated that precursors only
contributed 16% to the total PFOS intake. Even when including
(known) precursor contribution, the isomer pattern of total PFOS
intake cannot explain the PFOS isomer patterns and trends found in
human serum (Gebbink et al., 2015a). This lack of agreement be-
tween the temporal changes in isomer pattern of intake and serum
illustrates the incomplete understanding of isomer-speciﬁc phar-
macokinetic processes of PFAAs and their precursors.
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